Gait Adaptation for Stroke Patients With Augmented Reality (GASPAR)

December 5, 2017 updated by: Philippe Terrier

Visually-guided Gait Training in Paretic Patients During First Rehabilitation: a Randomized Controlled Trial

The GASPAR trial is a pragmatic, parallel-arms, single-center, non-blinded, superiority randomized control trial in neurorehabilitation. The main objective is to test whether a 4 weeks gait rehabilitation program that uses augmented reality is superior to a conventional treadmill training program of equivalent intensity. Baseline assessments precede allocation, which consists in blocking randomization (2:1 ratio) with stratification according to the disease etiology. Post-intervention assessments serve to compare the short-term efficacy of the intervention between the two groups. Three months after discharge, follow-up assessments take place to detect potential long-term effects.

Study Overview

Detailed Description

After a lesion to the central nervous system, many patients suffer from a diminished walking capability. During the first rehabilitation phase, specific cares help the recovery of motor function to offer the best chances of returning to normal walk. For example, the repeated practice of walking exercises facilitates the gain of muscular strength and stimulates motor relearning. However, in patients, who have finished the first rehabilitation phase, it is often observed strong limping, unsteady gait, and a bad management of obstacle clearance. Thus, these individuals fall frequently, with risk of severe injury. The aim of the study is to assess the efficacy of gait training on a treadmill equipped with an augmented reality system. Shapes are displayed onto the treadmill belt with a projector (beamer): the patient adapts his/her gait to the drawing that unfolds in front of him/her. It is possible to train gait symmetry for coordination enhancement or to exercise obstacle clearance and gait agility. Another advantage of this type of treadmill is the capability to continuously analyze gait with integrated sensors and, hence, to give real-time feedback to the patient. Whereas the method seems promising, thorough studies that would confirm its efficacy are lacking. Therefore, the investigators seek to conduct a randomized controlled trial to compare visually-guided gait training with a more classical training method. During four weeks, participants will train, according to their abilities, three to five times a week during 30 minutes on the augmented-reality treadmill. A group of control patients will train at comparable intensity but without the visual guidance of gait. Using the data collected during the training sessions, the investigators will study whether the evolution of locomotor function differs between both groups. Furthermore, several questionnaires will be filled in by the participants to document the self-evaluation of their progress. In the long term, the investigators expect to first improve the efficacy of gait rehabilitation and second to better understand the recovery process of locomotor function during the first months after a stroke.

Study Type

Interventional

Enrollment (Anticipated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Participants fulfilling all of the following inclusion criteria are eligible for the study:

  • Informed Consent as documented by signature
  • Stroke patients, patients with traumatic brain injury, or patients with spinal cord injury in the acute to sub-acute phase (maximum 40 days after the incident)
  • Need for gait rehabilitation in reason of at least one of the following conditions: Paresis of the lower extremities. Severe balance disorders. No walking at entry due to the neurological injury
  • Ability to walk 2 minutes without or with minimal aid, namely: With the help of one person, or: With walking aid (cane, walker)

The presence of any one of the following exclusion criteria will lead to exclusion of the participant:

  • Age < 18 years
  • Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.) that may threaten the health in case of sustained exercise.
  • Concomitant gait disorders induced by acute to sub-acute musculoskeletal injuries, e.g. fracture of the lower extremities.
  • Severe pre-existent gait disorders that deeply affect walking abilities and gait pattern, either due to musculoskeletal (e.g. severe osteoarthritis) or neurological (e.g. Parkinson's disease) etiologies.
  • Severe non-corrected visual impairment
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Augmented reality training
Gait training with augmented reality
20 sessions (30 min. duration) over 4 weeks of gait training with augmented reality.
ACTIVE_COMPARATOR: Standard training
Gait training without augmented reality
20 sessions (30 min. duration) over 4 weeks of gait training without augmented reality.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in walking speed
Time Frame: Pre-intervention (week 0), Post-intervention (week 5)
Walking speed, measured with the 2-minute walk test
Pre-intervention (week 0), Post-intervention (week 5)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in postural control
Time Frame: Pre-intervention (week 0), Post-intervention (week 5)
Capabilities to ensure an optimal postural control. Measured with the Berg Balance test
Pre-intervention (week 0), Post-intervention (week 5)
Fear of falling during the hospitalization
Time Frame: week 5
Subjective assessment of the fear of falling. Measured with the adapted Falls Efficacy Scale (FES)
week 5
Fear of falling at home
Time Frame: after discharge at 3-4 month
Subjective assessment of the fear of falling. Measured with the adapted Falls Efficacy Scale (FES)
after discharge at 3-4 month
Quality of life at home
Time Frame: after discharge at 3-4 month
Short-Form 36 questionnaire (SF-36)
after discharge at 3-4 month
Perception of the intervention
Time Frame: During the intervention, week 2 and 4
purpose-designed questionnaire that will ask to the participant about their perception of the intervention. The questionnaire will evaluate the satisfaction with intensity, duration and difficulty of the intervention. Other questions will ask about the perceived training effects on walking speed and confidence.
During the intervention, week 2 and 4
Changes in stride and step lengths
Time Frame: In every gait training sessions, from week 1 to week 4
Measured with the embedded sensors of the treadmills
In every gait training sessions, from week 1 to week 4
Changes in stride and step durations
Time Frame: In every gait training sessions, from week 1 to week 4
Measured with the embedded sensors of the treadmills
In every gait training sessions, from week 1 to week 4
Change in step width
Time Frame: In every gait training sessions, from week 1 to week 4
Measured with the embedded sensors of the treadmills
In every gait training sessions, from week 1 to week 4
Change in left/right asymmetry of step lengths
Time Frame: In every gait training sessions, from week 1 to week 4
Measured with the embedded sensors of the treadmills
In every gait training sessions, from week 1 to week 4
Change in left/right asymmetry of step durations
Time Frame: In every gait training sessions, from week 1 to week 4
Measured with the embedded sensors of the treadmills
In every gait training sessions, from week 1 to week 4
Changes in stance and swing phases
Time Frame: In every gait training sessions, from week 1 to week 4
Measured with the embedded sensors of the treadmills
In every gait training sessions, from week 1 to week 4
Change in gait variability
Time Frame: In every gait training sessions, from week 1 to week 4
Stride-to-stride variability of gait parameters (outcomes 7-12)
In every gait training sessions, from week 1 to week 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Philippe Terrier, PhD, Institute for Research in Rehabilitation and Clinique romande de réadaptation

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2016

Primary Completion (ANTICIPATED)

July 1, 2018

Study Completion (ANTICIPATED)

December 1, 2018

Study Registration Dates

First Submitted

June 14, 2016

First Submitted That Met QC Criteria

June 16, 2016

First Posted (ESTIMATE)

June 21, 2016

Study Record Updates

Last Update Posted (ACTUAL)

December 6, 2017

Last Update Submitted That Met QC Criteria

December 5, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

At the end of the study, final anonymized database will be made available through a specialized online repository

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Gait training with augmented reality

3
Subscribe